Infobird Replaces CEO and Chairman Xiangyang Wen with Yaqing Wei
IFBD sits 52% above its 52-week low of $0.66 on light trading volume (0.1× avg).
Summary
Infobird's CEO and chairman Xiangyang Wen resigned effective August 24, 2026, and Yaqing Wei was appointed to replace him across all roles, with a one-year employment agreement at HK$10,000 per month.
Key Events · Executive and Board Changes · IFBD
-
CEO and Chairman Resigns
Xiangyang Wen resigned as CEO, chairperson of the board, and director effective August 24, 2026, with no reason stated in the filing.
-
Yaqing Wei Appointed to All Roles
Yaqing Wei was appointed CEO, chairperson, director, and member of both the compensation and nomination/governance committees on the same day.
-
Employment Agreement Terms
Ms. Wei's agreement runs one year from August 24, 2026, with a monthly base salary of HK$10,000 and automatic 12-month extensions unless either party gives 60-day notice.
-
New CEO's Background
Ms. Wei has served as general manager of Beijing Aruisite Clinic Co., Ltd since May 2025 and previously held marketing roles at Zhongliang Group's alcohol and foods divisions — no disclosed experience in Infobird's software business.
Analysis · IFBD · Technology
A sudden CEO and chairman change at a company with an $8.2M market cap is a material governance event — leadership transitions of this scope often precede strategic shifts, and the new executive's background is in clinic management and alcohol marketing rather than the company's core customer-engagement software business. Infobird's CEO, chairman, and director Xiangyang Wen resigned effective August 24, 2026, and the board immediately appointed Yaqing Wei to all three roles plus seats on the compensation and nomination/governance committees. The employment agreement sets a one-year initial term with a modest HK$10,000 monthly base salary, suggesting the appointment may be transitional.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 29.6% of the 2856 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IFBD was trading at $1.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $8.2M. The 52-week trading range was $0.66 to $2.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.